Search all medical codes

Cyclosporine, oral, 25 mg

HCPCS code

Name of the Procedure:

  • Common Name(s): Cyclosporine, Oral
  • Technical/Medical Term(s): Administration of Cyclosporine, 25 mg (HCPCS Code J7515)

Summary

Cyclosporine is an oral medication commonly used to prevent organ rejection after a transplant. It is taken by mouth in a 25 mg dose and works by suppressing the immune system to prevent it from attacking the transplanted organ.

Purpose

  • Medical Conditions: Used primarily to prevent rejection in organ transplant patients (e.g., kidney, liver, heart).
  • Goals/Outcomes: Reduce the risk of organ rejection by modulating immune responses, ensuring the transplanted organ functions properly.

Indications

  • Symptoms/Conditions: Indicated for patients who have received an organ transplant and are at risk of rejection.
  • Patient Criteria: Suitable for post-transplant patients who require ongoing immunosuppression to maintain organ function.

Preparation

  • Pre-Procedure Instructions: Patients should inform their doctor of all medications they are taking, as some drugs can interact with Cyclosporine.
  • Diagnostic Tests: Regular blood tests are required to monitor kidney function and Cyclosporine levels.

Procedure Description

  • Step-by-Step Explanation:
    1. The patient receives specific dosage instructions from their healthcare provider.
    2. Cyclosporine is taken orally in a 25 mg capsule form, often twice daily.
  • Tools/Equipment: Oral capsules of Cyclosporine.
  • Anesthesia/Sedation: None required as it is an oral medication.

Duration

The medication is typically taken on a long-term, continuous basis as prescribed by the healthcare provider.

Setting

  • The medication is taken at home, but regular follow-ups with the healthcare provider are necessary.

Personnel

  • Healthcare Professionals: Primarily managed by a transplant specialist or general physician, supported by nurses and pharmacists.

Risks and Complications

  • Common Risks: Increased susceptibility to infections, hypertension, kidney dysfunction.
  • Rare Risks: Malignancies, severe allergic reactions.
  • Complications: Managed by adjusting the dosage or administering additional medications.

Benefits

  • Expected Benefits: Reduced risk of organ rejection.
  • Realization Time: Benefits are ongoing as long as the medication is taken as prescribed.

Recovery

  • Post-Procedure Care: Regular monitoring of blood levels and kidney function.
  • Recovery Time: There is no "recovery" time as it is a maintenance medication, but consistent use is critical.
  • Restrictions/Follow-Up: Regular visits to the healthcare provider for monitoring and dosage adjustments.

Alternatives

  • Other Options: Alternative immunosuppressants such as Tacrolimus or Mycophenolate Mofetil.
  • Pros/Cons: Alternatives may have different side effect profiles or interactions; suitability depends on the individual patient's medical condition and response.

Patient Experience

  • During the Procedure: The patient will take an oral capsule with water as prescribed.
  • After the Procedure: Patients may experience minor side effects like gastrointestinal discomfort. Pain management is generally not required unless complications arise.

Note: Cyclosporine must be taken exactly as prescribed, and patients should maintain regular follow-ups to monitor their health and medication levels.